Last reviewed: May 30, 2026
Last updated: May 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
NAD+ (nicotinamide adenine dinucleotide) supplementation typically ranges from $50–$300 monthly, depending on formulation, delivery route, and provider oversight. Injectable NAD+ and oral precursors (NMN, NR) carry different price points and evidence profiles.
Understanding NAD+ pricing requires more than sticker shock—it demands assessing whether supplementation aligns with your metabolic profile and wellness objectives. Personalized biomarker data and genetic context can inform whether NAD+ investment makes clinical sense for you.
What Drives NAD+ Supplementation Costs
NAD+ pricing reflects manufacturing complexity, formulation type, and regulatory oversight. Injectable NAD+ (administered by licensed providers) costs more due to sterility requirements and professional administration. Oral precursors like NMN and NR are cheaper but show variable absorption.
Provider involvement significantly impacts total cost. Telemedicine consultations add $150–$300 per visit; in-office NAD+ infusions include staff time and clinical monitoring, raising effective monthly spend. Compounding pharmacy services may offer cost flexibility through customized dosing protocols.
NAD+ Formulations and Their Price-to-Evidence Ratios
Different NAD+ pathways carry distinct costs and clinical support levels. Comparing formulations helps you align budget with evidence quality and personal metabolic needs. The table below outlines common options with pricing context and research status.
| Formulation |
Typical Monthly Cost |
Delivery Method |
Evidence Level |
| Oral NMN (Nicotinamide Mononucleotide) |
$60–$150 |
Capsule/powder |
Growing human studies; moderate bioavailability |
| Oral NR (Nicotinamide Riboside) |
$80–$200 |
Capsule |
Clinical trials ongoing; variable absorption |
| Injectable NAD+ (IV/IM) |
$200–$400 |
Professional injection |
Limited RCT data; high cost reflects administration |
| Compounded NAD+ Precursors |
$100–$250 |
Oral/injectable |
Customizable dosing; provider-guided protocols |
Biomarkers That Inform NAD+ Investment Decisions
Before committing to NAD+ supplementation, biomarker assessment can reveal whether depleted NAD+ levels actually contribute to your health concerns. Key markers include NAD+/NADH ratio, mitochondrial function indicators, and metabolic aging scores. Low baseline NAD+ may justify supplementation; normal levels may not.
Genetic factors influencing NAD+ metabolism and cellular aging pathways can provide context for whether supplementation aligns with your biology. Variants in genes affecting sirtuin activation, mitochondrial biogenesis, and NAD+-dependent processes may suggest personalized dosing or timing strategies.
Safety Considerations and Provider Oversight
NAD+ supplementation is generally well-tolerated, but quality control varies widely. Injectable NAD+ requires licensed provider administration; oral precursors lack FDA oversight. Compounding pharmacies accredited as 503A facilities maintain higher sterility and purity standards than unregulated supplements.
Medical supervision matters, especially if you take medications or have mitochondrial disease, cancer history, or metabolic conditions. A qualified provider can determine appropriate dosing, monitor for interactions, and assess whether NAD+ addresses your actual clinical needs rather than marketing hype.
How PlexusDx Supports a More Personalized Approach
PlexusDx's Precision Peptide Genetic Test may help provide context for metabolic aging and cellular energy pathways relevant to NAD+ decision-making. While the test focuses on peptide genetics, understanding your predispositions in mitochondrial and metabolic aging processes can support a more informed conversation with your provider about whether NAD+ supplementation aligns with your biology.
Genetic variants in pathways like sirtuin activation and mitochondrial biogenesis should be interpreted with a qualified healthcare provider—they predict predispositions in cellular aging, not exact NAD+ response or supplement need. The test cannot guarantee that supplementation will improve outcomes, but context about your genetic background can inform personalized wellness strategy.
Combining biomarker assessment with genetic predisposition data helps you evaluate NAD+ cost against clinical relevance. Rather than treating supplementation as a one-size approach, this precision context supports a more meaningful conversation with your provider about whether NAD+ investment addresses your specific metabolic needs and health goals.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the average monthly cost of NAD+ supplementation?
Monthly NAD+ costs range from $50–$400 depending on formulation and delivery method. Oral precursors (NMN, NR) typically cost $60–$200; injectable NAD+ ranges $200–$400, including professional administration. Provider oversight adds consultation fees.
Is injectable NAD+ more effective than oral forms?
Injectable NAD+ bypasses absorption variability, but clinical evidence comparing routes remains limited. Oral NMN and NR show effectiveness in emerging human studies, though bioavailability differs between individuals. Provider guidance should determine which route suits your health profile.
How does PlexusDx genetic testing relate to NAD+ decision-making?
PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic and mitochondrial aging pathways. Understanding your genetic context may help inform whether NAD+ supplementation aligns with your biology, supporting a more personalized conversation with your provider.
Are there safety risks with long-term NAD+ supplementation?
NAD+ precursors are generally safe, but long-term human safety data remains limited. Potential interactions with medications or conditions like cancer warrant provider evaluation. Quality control through accredited 503A compounding pharmacies reduces contamination risk versus unregulated supplements.
What biomarkers should I check before starting NAD+ supplementation?
NAD+/NADH ratio, mitochondrial function markers, and metabolic age scores can reveal whether low NAD+ actually contributes to your concerns. Genetic assessment of cellular aging pathways provides additional context for personalized supplementation strategy and dosing decisions.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Mic B12 Dosage: Biomarker-Guided Approaches and Clinical Optimization
Where To Buy Glutathione: Clinical Evidence and Provider-Guided Options